PETER SCHANEN: Open Payments
NPI 1720491442 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$952 in 33 payments from 15 companies in 2025. Trend: 2023 $1,157 · 2024 $419 · 2025 $952
Food & beverage: $952
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $187 |
| Novo Nordisk Inc | 5 | $172 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $84 |
| Exact Sciences Corporation | 4 | $78 |
| ABBVIE INC. | 3 | $72 |
| ALK-Abello, Inc | 2 | $60 |
| Lilly USA, LLC | 2 | $44 |
| TOLMAR, INC. | 2 | $44 |
| IBSA Pharma Inc. | 2 | $43 |
| SHIELD THERAPEUTICS INC | 2 | $35 |
Products named: BREZTRI, Wegovy, Kerendia, Grastek, JATENZO, Tirosint, ACCRUFER, JOURNAVX.
Industry payments across TX — which companies pay providers there.
